ArticleJournal of molecular medicine (Berlin, Germany)2020
Targeting TJP1 attenuates cell-cell aggregation and modulates chemosensitivity against doxorubicin in leiomyosarcoma.
Eun-Young Lee et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it